Cogent Biosciences Stock 346% Surge Fueled by New Stake
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
Demonstrating your value is crucial for securing a salary increase. Learn effective methods to showcase your contributions and worth.
21,252 articlesA Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
A dramatic streaming deal sparks a rally in Paramount Skydance and reshapes the media landscape. This guide breaks do...
A sizable stake emerged as H&R Block faced a meaningful slide. This article breaks down what a block stock down inves...
Novo Nordisk has drifted toward a five-year low, raising questions about value vs. risk. This guide breaks down the f...
Venture firm Andreessen Horowitz and a growing mix of banks push a five-year horizon for autonomous AI agents to func...
Analysts highlight three candidates with durable networks and real use cases, exploring chances for outsized gains by...
Celebrities walk a fine line between humor and harm. When kevin hart says oprah is off-limits, it reveals how powerfu...
Can Nvidia keep leading in AI and data centers through 2030? This in-depth look lays out three scenarios, key drivers...
SpaceX's IPO excitement gave way to a pullback, leaving investors wondering about future gains. This guide breaks dow...
A high-profile trademark dispute around the 1587 Prime restaurant tests more than litigation—it tests how branding, c...
Warren Buffett’s blunt warning that today’s market mood resembles gambling hits a nerve with everyday investors. This...
Six big forces could redefine how we borrow, buy, and refinance in 2026. This guide breaks down the economy, the hous...